Grünenthal Acquires Kyowa Kirin’s 49% Stake in Grünenthal Meds JV
March 2, 2026
Grünenthal acquired Kyowa Kirin International’s 49% stake in Grünenthal Meds, taking full ownership of the joint venture created in 2023 to market Grünenthal’s established medicines portfolio. The JV manages a portfolio of 12 established brands across six therapeutic areas and more than 60 markets, with key products including Abstral, PecFent, Moventig, and Adcal-D3.
- Buyers
- Grünenthal
- Targets
- Grünenthal Meds
- Sellers
- Kyowa Kirin International
- Industry
- Pharmaceuticals
- Location
- United Kingdom
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.